A Path to Precision Medicine in Prostate Cancer: Learning from "Negative" Trials of Targeted Therapies. Dorff TB, Morgans AK. Eur Urol 2022 Aug 6. pii: S0302-2838(22)02527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dorff TB, Morgans AK. A Path to Precision Medicine in Prostate Cancer: Learning from "Negative" Trials of Targeted Therapies. Eur Urol 2022 Aug 6. pii: S0302-2838(22)02527.
PMID: 35945086